STING1 and cancer: The cGAS-STING pathway is the principle cellular cytosolic double-stranded DNA (dsDNA) sensor, leading to type I IFN release and facilitating innate immune responses to infections and cancer [28], and is required for efficacy of immune checkpoint blockade immunotherapy in cancer models [29].